These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10965912)

  • 1. Adenosine is an agonist of the growth hormone secretagogue receptor.
    Tullin S; Hansen BS; Ankersen M; Møller J; Von Cappelen KA; Thim L
    Endocrinology; 2000 Sep; 141(9):3397-402. PubMed ID: 10965912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors.
    McKee KK; Palyha OC; Feighner SD; Hreniuk DL; Tan CP; Phillips MS; Smith RG; Van der Ploeg LH; Howard AD
    Mol Endocrinol; 1997 Apr; 11(4):415-23. PubMed ID: 9092793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine: A partial agonist of the growth hormone secretagogue receptor.
    Smith RG; Griffin PR; Xu Y; Smith AG; Liu K; Calacay J; Feighner SD; Pong C; Leong D; Pomés A; Cheng K; Van der Ploeg LH; Howard AD; Schaeffer J; Leonard RJ
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1306-13. PubMed ID: 11027627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.
    Cunha SR; Mayo KE
    Endocrinology; 2002 Dec; 143(12):4570-82. PubMed ID: 12446584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland.
    Muccioli G; Papotti M; Locatelli V; Ghigo E; Deghenghi R
    J Endocrinol Invest; 2001 Mar; 24(3):RC7-9. PubMed ID: 11314756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary.
    Nass R; Gilrain J; Anderson S; Gaylinn B; Dalkin A; Day R; Peruggia M; Thorner MO
    Endocrinology; 2000 Jun; 141(6):2084-9. PubMed ID: 10830294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites.
    Bresciani E; Nass R; Torsello A; Gaylinn B; Avallone R; Locatelli V; Thorner MO; Müller EE
    Neuroendocrinology; 2004; 80(1):52-9. PubMed ID: 15361691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C.
    Falls HD; Dayton BD; Fry DG; Ogiela CA; Schaefer VG; Brodjian S; Reilly RM; Collins CA; Kaszubska W
    J Mol Endocrinol; 2006 Aug; 37(1):51-62. PubMed ID: 16901923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine inhibits prolactin and growth hormone secretion in a clonal pituitary cell line.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1985 Dec; 117(6):2330-8. PubMed ID: 2998734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine does not bind to the growth hormone secretagogue receptor type-1a (GHS-R1a).
    Carreira MC; Camiña JP; Díaz-Rodríguez E; Alvear-Perez R; Llorens-Cortes C; Casanueva FF
    J Endocrinol; 2006 Oct; 191(1):147-57. PubMed ID: 17065398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus.
    Tannenbaum GS; Lapointe M; Beaudet A; Howard AD
    Endocrinology; 1998 Oct; 139(10):4420-3. PubMed ID: 9751527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structure.
    Liantonio A; Gramegna G; Carbonara G; Sblendorio VT; Pierno S; Fraysse B; Giannuzzi V; Rizzi L; Torsello A; Camerino DC
    Endocrinology; 2013 Oct; 154(10):3764-75. PubMed ID: 23836033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland.
    Muccioli G; Ghè C; Ghigo MC; Papotti M; Arvat E; Boghen MF; Nilsson MH; Deghenghi R; Ong H; Ghigo E
    J Endocrinol; 1998 Apr; 157(1):99-106. PubMed ID: 9614363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone inhibition of growth hormone release stimulated by a growth hormone secretagogue: studies in the rat and dog.
    Rigamonti AE; Cella SG; Giordani C; Bonomo SM; Giunta M; Sartorio A; Muller E
    Neuroendocrinology; 2006; 84(2):115-22. PubMed ID: 17106185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortistatin mimics somatostatin by inducing a dual, dose-dependent stimulatory and inhibitory effect on growth hormone secretion in somatotropes.
    Luque RM; Peinado JR; Gracia-Navarro F; Broglio F; Ghigo E; Kineman RD; Malagón MM; Castaño JP
    J Mol Endocrinol; 2006 Jun; 36(3):547-56. PubMed ID: 16720722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors.
    Korbonits M; Bustin SA; Kojima M; Jordan S; Adams EF; Lowe DG; Kangawa K; Grossman AB
    J Clin Endocrinol Metab; 2001 Feb; 86(2):881-7. PubMed ID: 11158061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats.
    Shuto Y; Shibasaki T; Wada K; Parhar I; Kamegai J; Sugihara H; Oikawa S; Wakabayashi I
    Life Sci; 2001 Jan; 68(9):991-6. PubMed ID: 11212874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.